News & Media
Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges
- Assess the value of oncology therapeutics;
- Discuss value-based treatment decision and ethical concerns of expensive drugs;
- Summarize the scope of unethical tactics and actions physicians may take; and,
- Identify ways in which the introduction of money into medical practice and research can create conflicts of interest and perverse financial incentives.
Additionally, Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges will explain the concepts of exploitation and undue influence, examine strategies for prioritizing access to Hepatitis C drugs when resource constraints prevent access, and recognize and explain challenges the direct-to-consumer industry presents. During the meeting, experts will present research and network with colleagues. Program is planned for health care professionals by physicians. Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges allows physician attendees to earn up to 7 AMA PRA Category 1 Credit(s)™ during this one-day event.
To register or for more information on the MSMS Foundation's Ethical Issues in the Pharmaceutical Industry: Current Controversies and Challenges conference, please visit http://msms.org/eo.
Statement of Accreditation: The Michigan State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement: The Michigan State Medical Society designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.